Evidence map›Paper›PMID 29973195›Full record

Trial reportBMC complementary and alternative medicine2018

Effects of a hydroalcoholic extract of Juglans regia (walnut) leaves on blood glucose and major cardiovascular risk factors in type 2 diabetic patients: a double-blind, placebo-controlled clinical trial.

Khadijeh Rabiei, Mohammad Ali Ebrahimzadeh, Majid Saeedi, Adele Bahar, Ozra Akha, Zahra Kashi

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Nutritional Advantages of Walnut (Food science & nutrition · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. The hypoglycemic effects ofJournal of cardiovascular and thoracic research · 2023
    Article
  11. Review
  12. Article
  13. The Effect of Walnut (Clinical nutrition research · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Khadijeh RabieiWorld Federation of Acupunture-Moxibustion Societies (WFAS), Scientific Studies Institute of Nadali Esmaeili, Acupuncture Center, Sari, Iran.
Mohammad Ali EbrahimzadehPharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Majid SaeediPharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Adele BaharDiabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Ozra AkhaDiabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Zahra KashiDiabetes Research Center, Mazandaran University of Medical Sciences, Sari, Iran. kashi_zahra@yahoo.com.ORCID http://orcid.org/0000-0002-4683-1323
Mazandaran University of Medical Sciences · IR

Funding

Mazandaran University of Medical Sciences CT-P-92-5670
6 · The paper itself

Abstract

backgroundWe aimed to evaluate the effects of a hydroalcoholic extract of Juglans regia L. leaves on blood glucose level and cardiovascular risk factors in type 2 diabetic patients.

methodsIn this randomized, double-blind, placebo-controlled, parallel-group (2 arms) clinical trial, 50 diabetic patients were divided into two groups: treatment group (receive the capsules containing 100 mg J. regia leaf extract) and control group (receive the capsules containing placebo, microcrystallin cellulose). Baseline participant data were matched between the two arms of the study. We administered the prepared capsules to the patients twice daily for 8 weeks. Blood glucose level, glycosylated hemoglobin (HbA1c) level, body weight, body mass index, blood pressure, lipid profile, serum insulin, and insulin resistance were compared between the two groups before and after the intervention. P < 0.05 was considered significant.

resultsAfter excluding eleven patients, 20 received J. regia leaf extract and 20 patients received placebo. The J. regia leaf extract did not significantly change the blood glucose and insulin resistance condition. However, in this group, body weight, body mass index, and systolic blood pressure significantly decreased compared with the baseline measurements (P = 0.028, P = 0.030, and P = 0.005, respectively). The lipid profile did not change significantly compared with the baseline measurements. In the control group, postprandial glucose and HbA1c levels significantly decreased after the intervention (P = 0.030 and P = 0.028, respectively). The other variables were not significantly different in this group. At the end of the study, the variables were not significantly different between the two groups.

conclusionIn this double-blind study, 200 mg/d of J. regia leaf extract had no significant effect on blood glucose level and HOMA-IR score in patients with type 2 diabetes. However, the J. regia leaf extract was effective in reducing body weight and blood pressure. An accidental finding of our study was that microcrystalline cellulose, a widely used placebo in clinical trials, led to a reduction in blood glucose level.

trial registrationIranian Registry of Clinical Trials (IRCT: 138901203180 N2 , 2010/6/6); retrospectively registered.

Indexed as

AdultAgedAged, 80 and overBlood GlucoseBlood PressureCardiovascular DiseasesCholesterolDiabetes Mellitus, Type 2FemaleHumansJuglansLipidsMaleMiddle AgedPlant ExtractsPlant LeavesBlood GlucoseCholesterolLipidsPlant ExtractsAvicelBlood glucoseBlood pressureCardiovascularDiabetes mellitusHerbal medicineJuglans regiaMicrocrystalline celluloseWalnut leavesWeight

Identifiers

PMID29973195
PMCPMC6031195
OpenAlexW2810673588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.